Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
Frontiers in Oncology|November 17, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancerNuradh Joseph, Alessandro Cicchetti, Alan McWilliam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancerHarkeran K Jandu, Colin D Veal, Laura Fachal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate CancerManzur Farazi, Xin Yang, Carson J Gehl, et al.
Breast (Edinburgh, Scotland)|June 26, 2025
Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapyEster Aguado-Flor, Victoria M Reyes, Víctor Navarro, et al.
Advances in Radiation Oncology|June 1, 2022
Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE CohortMahmoud Aldraimli, Sarah Osman, Diana Grishchuck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 4, 2022
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE studyLotte van der Weijst, David Azria, Patrick Berkovic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2021
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicityNicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2022
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)Lotte Van der Weijst, Miguel E Aguado-Barrera, David Azria, et al.
Frontiers in Oncology|November 12, 2020
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National CohortMichela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, et al.
Pageof 9